Pfizer | PFE - Marktkapitalisierung





Marktkapitalisierung Veränderung Datum
Abbott USD 171.01B 12.96B 2026-09
ALKERMES USD 8.73B 2.85B 2026-06
Amgen USD 195.44B 5.55B 2026-06
Bayer EUR 47.56B 8.87B 2026-06
Biogen USD 33.38B 1.48B 2026-09
Bristol-Myers Squibb USD 127.46B 9.81B 2026-09
Coherus Biosciences USD 172M 19M 2025-12
Drreddys Laboratories INR 11.07B 619M 2026-03
Eli Lilly USD 1.09T 40.33B 2026-09
Gilead Sciences USD 184.82B 27.96B 2026-09
GlaxoSmithKline GBP 74.11B 6.03B 2026-09
Glaxosmithkline GBP 109.29B 9.36B 2026-03
J&J USD 653.61B 42.25B 2026-09
Medtronic USD 109.3B 2.33B 2026-06
Merck USD 358.5B 41.13B 2026-09
Neurocrine Biosciences USD 16.95B 3.7B 2026-06
Novartis USD 288.26B 25.18B 2026-03
Pacira USD 998M 83M 2026-06
Pfizer USD 138.44B 15.37B 2026-06
Phibro Animal Health USD 1.51B 126M 2025-12
Prestige Brands USD 2.24B 566M 2026-06
Roche Holding CHF 270B 3.66B 2026-06
Sanofi EUR 113.52B 3.82B 2026-03
Vertex Pharmaceuticals USD 126.07B 12.49B 2026-06
Zoetis USD 30.13B 19.58B 2026-06